Endo, Watson Settle Litigation Over Opana ER Generic
Endo Pharmaceuticals Inc. has resolved litigation against Watson Pharmaceuticals Inc. over Watson's proposed generic version of the painkiller Opana ER, with Endo granting Watson a royalty-free license to U.S. patents covering...To view the full article, register now.
Already a subscriber? Click here to view full article